GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Artificial Intelligence /AI-assisted versus conventional reading in pan-intestinal capsule endoscopy
29

AI-assisted versus conventional reading in pan-intestinal capsule endoscopy

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated November 1, 2025

The comparison between AI-assisted pan-intestinal capsule endoscopy (AI-PCE) and conventional reading of pan-intestinal capsule endoscopy (CR-PCE) highlights significant advancements in the diagnostic capabilities of AI technology in the context of suspected mid-lower gastrointestinal bleeding (MLGIB). Here’s a detailed breakdown:

Overview of Pan-Intestinal Capsule Endoscopy (PCE)

PCE is a minimally invasive diagnostic tool used to evaluate the gastrointestinal (GI) tract, particularly for detecting potentially haemorrhagic lesions (PHLs) in cases of suspected MLGIB. While effective, the traditional method of reading PCE (CR-PCE) is labor-intensive, time-consuming, and prone to variability and missed lesions due to human error.

AI-Assisted PCE (AI-PCE)

AI-PCE employs artificial intelligence, specifically a convolutional neural network (CNN), to assist in detecting lesions within the GI tract. This technology automates the lesion detection process, potentially improving diagnostic accuracy and efficiency.


Key Findings from the Study

1. Improved Sensitivity and Negative Predictive Value (NPV)

AI-PCE demonstrated significantly higher sensitivity and NPV compared to CR-PCE:

  • Sensitivity: AI-PCE achieved a sensitivity of 95% overall, compared to 67% for CR-PCE. This means AI-PCE was much more effective at detecting lesions.
  • Negative Predictive Value (NPV): AI-PCE had an NPV of 92% versus 63% for CR-PCE, indicating a reduced likelihood of missing lesions.

2. Performance by Intestinal Segment

  • Small Bowel:
  • Sensitivity: 96% (AI-PCE) vs. 59% (CR-PCE).
  • NPV: 97% (AI-PCE) vs. 76% (CR-PCE).
  • Colon:
  • Sensitivity: 90% (AI-PCE) vs. 68% (CR-PCE).
  • NPV: 94% (AI-PCE) vs. 86% (CR-PCE).

3. Lesion Detection

AI-PCE outperformed CR-PCE in detecting various lesion types:

  • Vascular Lesions: 51% detection rate with AI-PCE vs. 33% with CR-PCE.
  • Ulcers/Erosions: 16% detection rate with AI-PCE vs. 7% with CR-PCE.
  • Protuberant Lesions: Comparable detection rates (5% vs. 4%).
  • Active Bleeding: Comparable detection rates (7% vs. 7%).

4. Comparison with Colonoscopy

AI-PCE also outperformed traditional colonoscopy:

  • Sensitivity: 90% (AI-PCE) vs. 32% (colonoscopy).
  • Positive Predictive Value (PPV): 100% (AI-PCE) vs. 65% (colonoscopy).
  • NPV: 94% (AI-PCE) vs. 65% (colonoscopy).

Advantages of AI-PCE Over CR-PCE and Colonoscopy

  1. Higher Diagnostic Accuracy: AI-PCE provides significantly better sensitivity and NPV, reducing the risk of missed lesions.

  2. Minimally Invasive: Unlike colonoscopy, PCE is non-invasive, making it a more comfortable option for patients.

  3. Consistency and Reliability: AI reduces reader dependency, variability, and the likelihood of human error in lesion detection.

  4. Time Efficiency: Automating the review process with AI can save time for clinicians.


Implications for Research, Practice, and Policy

  1. Redefining Diagnostic Standards: AI-PCE may become the first-line diagnostic tool for suspected MLGIB, reducing the reliance on invasive procedures like colonoscopy.

  2. Improved Patient Outcomes: By reducing false negatives, AI-PCE can decrease the need for repeated procedures and enhance early detection of critical lesions.

  3. Integration of AI into Clinical Workflows: The study supports the incorporation of AI into capsule endoscopy to improve diagnostic accuracy and efficiency.

  4. Future Research: Further validation studies and cost-effectiveness analyses are necessary to confirm the widespread applicability of AI-PCE.


Conclusion

AI-assisted PCE represents a significant advancement over conventional reading methods and even colonoscopy in the diagnosis of suspected MLGIB. With its superior sensitivity, reliability, and minimally invasive nature, AI-PCE has the potential to revolutionize the diagnostic approach to gastrointestinal bleeding and set a new standard for clinical practice. However, further research is needed to validate these findings and address the cost implications of integrating AI into routine diagnostic workflows.

Related Q&A

30

Machine learning in GI Endoscopy

Machine learning (ML) has revolutionized gastrointestinal (GI) endoscopy by improving diagnostic precision, reducing variability, and streamlining workflows. ML algorithms analyze endoscopic images or videos to detect patterns, identify...

31

Submucosal vessel detection during third-space endoscopy - Role of AI

The role of artificial intelligence (AI) in submucosal vessel detection during third-space endoscopy, such as endoscopic submucosal dissection (ESD) and peroral endoscopic myotomy (POEM), has been explored to...

32

CADe colonoscopy in colorectal cancer screening - ESGE Postional Statement

The ESGE (European Society of Gastrointestinal Endoscopy) Position Statement on computer-assisted detection (CADe) in colonoscopy for colorectal cancer (CRC) screening and post-polyp surveillance provides a cautious but favorable...

33

AI for submucosal vessel detection during third-space endoscopy

Submucosal vessel detection is critically important in third-space endoscopy because this advanced procedure involves creating a pathway within the layers of the gastrointestinal wall to treat conditions like...

34

Cancer Recurrence in Patients With CRC - Role of AI

The role of AI in detecting and analyzing cancer recurrence in patients with colorectal cancer (CRC) has been transformative, particularly with advancements like the DFCI-imaging-student model. Below is...

35

AI ML-based nomogram for mortality risk stratification in cirrhotic patients

The AI/ML-based nomogram developed in this study serves as a predictive tool for estimating in-hospital mortality risk among cirrhotic patients with sepsis. This retrospective single-center study analyzed data...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer